Health ❯ Healthcare ❯ Diabetes ❯ Type 2 Diabetes

GLP-1 Medications

Stopping GLP-1 Weight-Loss Drugs Before Pregnancy Linked to Higher Gestational Risks, Study Finds

The retrospective Mass General Brigham analysis of 2016–2025 deliveries appears in JAMA Network Open.

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial